Liminatus Pharma Total Liabilities 1971-1970 | LIMN

Liminatus Pharma total liabilities from 1971 to 1970. Total liabilities can be defined as the total value of all possible claims against the corporation.
Liminatus Pharma Annual Total Liabilities
(Millions of US $)
Liminatus Pharma Quarterly Total Liabilities
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $2.052B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.233B 0.00
Aduro Clean Technologies (ADUR) Canada $0.178B 0.00
Range Capital Acquisition (RANG) United States $0.142B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.102B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.090B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.042B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.028B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
Smart Digital Group (SDM) $0.000B 0.00
Winchester Bancorp (WSBK) $0.000B 0.00
Yuanbao - (YB) China $0.000B 0.00
Cantor Equity Partners II (CEPT) $0.000B 0.00